Shamika Walsh
Family · Marrero, LANPI 1902114374
Payments from drug & device makers
Across 63 payments — averaging $36.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$244
- AbbVie$243
- Sanofi$240
- Teva Pharmaceuticals USA, Inc.$167
- Lilly USA, LLC$140
- AstraZeneca$140
- plus $1K from 17 others
What the payments were for
- Food & beverage$2,310100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 10 | $244 |
| AbbVie | 2 | $243 |
| Sanofi | 2 | $240 |
| Teva Pharmaceuticals USA, Inc. | 2 | $167 |
| Lilly USA, LLC | 8 | $140 |
| AstraZeneca(2 entities) | 3 | $140 |
| Abbott | 1 | $128 |
| Sumitomo Pharma America, Inc. | 1 | $125 |
| Amgen | 1 | $114 |
| Medtronic | 1 | $111 |
| Boehringer Ingelheim | 5 | $102 |
| Nevro Corp. | 2 | $98 |
| Merck | 6 | $98 |
| GSK | 4 | $82 |
| Sanofi-aventis U.S. LLC | 3 | $63 |
| Pfizer | 3 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Exact Sciences | 1 | $24 |
| Idorsia Pharmaceuticals US Inc | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$237
- FreeStyle Libre 2$128
- Humira$125
- GEMTESA$125
- Austedo XR$122
- Wegovy$122
- FABRAZYME$122
- LINZESS$118
- KRYSTEXXA$114
- SYNCHROMEDII$111
How this compares
$2,310 in reported general payments places this provider in the 75th percentile of 3,610 family providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 12 | $138 |
Paid to pharmacies, not to this prescriber.
Other family in Marrero
- Sharon JacksonMarrero$13K
- Jolie MontreuilMarrero$13K
- Rebecca EzellSlidell$268K
- Erin PierceNew Orleans$261K
- Tavell KindallNew Orleans$194K
- Ashlea HillRuston$169K
- Brittany MillerVille Platte$158K
- Ryanne ClarkeGretna$123K
- Elidia DewittBaton Rouge$108K
- Rebekah GarrardLafayette$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.